|

Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

RECRUITINGN/ASponsored by Cedars-Sinai Medical Center
Actively Recruiting
PhaseN/A
SponsorCedars-Sinai Medical Center
Started2025-04-07
Est. completion2027-02-28
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06877169

Summary

The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.

Exclusion Criteria:

* Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
* Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.

Conditions4

Chronic Kidney DiseaseEnd Stage Kidney DiseaseHeart DiseaseHeart Failure

Locations1 site

Cedars-Sinai Medical Center
Los Angeles, California, 90048
Justin A Steggerda, M.D.310-423-3276justin.steggerda@cshs.org

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.